Our Science

Filter Science by Keyword

Filter science by

Webinar
Applied BioMath Assess™ - An Early Feasibility Assessment Tool for Biotherapeutics
Disease Area
Modality
View Details
Fact Sheet
Understanding the PK/PD Continuum
Disease Area
  • Other
Modality
  • Other
View Details
Case Study
Early Feasibility Assessment of an anti-TNF Biotherapeutic
Disease Area
Modality
View Details
Collaboration
Publication
Quantitative modeling predicts competitive advantages of a next generation anti‐NKG2A therapy over monalizumab for the treatment of cancer
Collaboration with KSQ Therapeutics - Published in CPT: Pharmacometrics Systems Pharmacology
Disease Area
  • Immuno-oncology
Modality
  • mAb
View Details
Collaboration
Publication
Model-Informed Drug Development of the Masked Anti-PD-L1 Antibody CX-072
Collaboration with CytomX Therapeutics - Published in Clinical Pharmacology & Therapeutics
Disease Area
  • Oncology
Modality
  • mAb
View Details
Collaboration
Publication
Fibrinolytic Therapy for Refractory COVID‐19 Acute Respiratory Distress Syndrome: Scientific Rationale and Review
Collaboration with MIT - Published in Research and Practice in Thrombosis and Haemostasis
Disease Area
  • Virology
Modality
  • Other
View Details
Collaboration
Publication
QSP Model of Colonic Motility
Collaboration with Takeda - Published in Journal of Pharmacokinetics and Pharmacodynamics
Disease Area
  • Inflammation and Immunology
Modality
  • Small Molecule
View Details
Collaboration
Poster
Phase 1 Safety of ICOS Agonist Antibody JTX-2011 Alone and with Nivolumab in Advanced Solid Tumors
Collaboration with Jounce - Presented at ASCO Annual Meeting 2017
Disease Area
  • Oncology
Modality
  • mAb
View Details
Fact Sheet
Conference Presence with Partners
Disease Area
  • Other
Modality
  • Other
View Details
Fact Sheet
Corporate Fact Sheet
Disease Area
  • Other
Modality
  • Other
View Details
Publication
Mechanistic Quantitative Pharmacology Strategies for the Early Clinical Development of Bispecific Antibodies in Oncology
Published in Clinical Pharmacology & Therapeutics
Disease Area
  • Oncology
Modality
  • Bispecific
View Details
Collaboration
Webinar
Translational Modeling Strategies to Predict Clinical Doses for CD3 Bispecific Molecules
Collaboration with Pfizer - Presented by Alison Betts, Applied BioMath
Disease Area
  • Oncology
Modality
  • Bispecific
View Details